Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-062290
Filing Date
2019-12-31
Accepted
2019-12-31 16:37:32
Documents
1
Period of Report
2019-12-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7910
  Complete submission text file 0001209191-19-062290.txt   9448
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Issuer) CIK: 0001107421 (see all company filings)

EIN.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ZIOPHARM ONCOLOGY, INC. 1 FIRST AVE, PARRIS BUILDING #34 BOSTON MA 02129
Business Address
Cooper Laurence James Neil (Reporting) CIK: 0001641506 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33038 | Film No.: 191319817